🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This video as Dr. Walsh says is a "must watch" for anyone interested in prostate cancer especially urology learners. Just watched it- Epstein does a great job! David M. Berman Matthew Wasco @JGordetsky Tamara Lotan, MD youtube.com/watch?v=9ff-94…

Results of the SPPORT trial #radonc - short term ADT + extending field of radiation in men with detectable #psa post prostatectomy improves outcomes #ProstateCancer Alan Pollack, MD, PhD @felixfangmd thelancet.com/journals/lance…

sciencedirect.com/science/articl… #ProstateCancer

Huge congrats 🎉🎉 to Mark Yarchoan on his recent promotion to Assoc Professor of #Oncoloy Johns Hopkins Kimmel Cancer Center Johns Hopkins Hematology and Oncology Fellowship doing such great work on #livercancer and #Immunotherapy toxicity!!

Evidence supporting #healthy living for men at risk for #ProstateCancer sciencedirect.com/science/articl… @loreleimucci

Interesting NEJM letter & hypothesis on AR blockade-induced #hypertension. There are data! Perhaps time to reshare our Annals of Oncology paper on how AR blockade affects biochemical loss of 11BHSD2 which can explain HTN. @gulleyj1 Eric Klein Mohammad Alyamani, PhD annalsofoncology.org/article/S0923-…

Following today’s Supreme Court decision to overturn Roe v. Wade, leaders from Johns Hopkins University and Johns Hopkins Medicine shared a message today affirming our commitment to following evidence-based best practices to the fullest extent of the law. bit.ly/3yl86ec

❤️cardiovascular events and association with immune checkpoint inhibitors ascopubs.org/doi/full/10.12…

interesting article here about way to identify people who might be able to avoid prostate biopsy and just go strait to surgery. very small study but raises some interesting questions... sciencedirect.com/science/articl…

And a guide to bipolar androgen therapy...high dose testosterone + androgen deprivation therapy to treatment advanced prostate cancer. onlinelibrary.wiley.com/doi/full/10.10…

Delighted to share our review article on CHIP in solid tumors. Congrats to Cathy Handy Marshall, MD MPH Lukasz Gondek aacrjournals.org/cancerres/arti…

nejm.org/doi/full/10.10…

fda.gov/drugs/resource…

#cancer and #cardiovascular disease ascopubs.org/doi/full/10.12…

#metastasis directed therapy in #ProstateCancer update by Matthew P Deek and colleagues ascopubs.org/doi/10.1200/JC…

argument in favor of continuing to allow #telemedicine across state lines! nejm.org/doi/full/10.10…

results from pembro + olaparib in #mcrpc PSA response rate 15%; ORR 8.5%; treatment related grade 3-5 AE 48% and deaths due to AEs in 5.9% europeanurology.com/article/S0302-…

Congratulations to Lustgarten's Chief Medical Advisor Dr. Elizabeth Jaffee on the 2022 Association of American Cancer Institutes Distinguished Scientist Award for her groundbreaking research in treating pancreatic cancer with immunotherapy. Johns Hopkins Kimmel Cancer Center #AACI2022

Having a great time at #ASCO2023 with mentor Emmanuel Antonarakis presenting work on olaparib mono therapy in prostate cancer on behalf of

Our haiku about #prostatecancer and the #PCFRetreat24 with Prostate Cancer Foundation by Pedro F. S. Freitas, MD Sylvan Baca MD PhD (Hiring!) What do you think? 😊 Rana McKay, MD, FASCO Emmanuel Antonarakis Mark C. Markowski Toni Choueiri, MD Howard Soule Andrea Miyahira Misha Beltran Josh Lang